首页> 外文期刊>Photodermatology, photoimmunology and photomedicine >The impact of different fluence rates on pain and clinical outcome in patients with actinic keratoses treated with photodynamic therapy.
【24h】

The impact of different fluence rates on pain and clinical outcome in patients with actinic keratoses treated with photodynamic therapy.

机译:光动力疗法治疗的光化性角化病患者不同通量率对疼痛和临床结局的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND/PURPOSE: Literature data suggest that lower fluence rates are preferable in terms of clinical response and tolerability for treating patients with actinic keratoses (AKs). We aimed to clarify the impact of different fluence rates on pain during photodynamic therapy (PDT) for AKs, as well as on treatment outcome. METHODS: Individuals with at least three discrete AKs were recruited. Each lesion was randomly allocated to 25, 50 or 75 mW/cm2 of topical 5-aminolevulinic acid (5-ALA) PDT, using non-coherent light source. Primary end point was pain during illumination, evaluated using a visual analogue scale (VAS). Secondary end points were clinical outcome and adverse events. RESULTS: Fifty adults, with 150 AKs lesions were recruited in the study. Mean VAS score did not significantly differ between the groups of 25 and 50 mW/cm2 (P=0.714). However, mean VAS was significantly higher at the group of 75 mW/cm2 in comparison to the former ones (P=0.000). With respect to the clinical outcome and adverse events during the first year of follow-up, no differences were observed between the three groups. Comparison between the 25 and the 50 mW/cm2 (P=0.749), as well as between the former and the 75 mW/cm2, did not show a dependence of complete response rate on fluence (P=0.749 and P=1.000, respectively). CONCLUSIONS: According to our observations a fluence rate between 25 and 50 mW/cm2 is effective and better tolerated by patients treated with topical 5-ALA PDT for AKs.
机译:背景/目的:文献数据表明,就临床反应和光化性角化病(AKs)患者的耐受性而言,较低的注量率是可取的。我们的目的是阐明光通量治疗对AKs进行光动力治疗(PDT)时疼痛对疼痛的影响以及对治疗结果的影响。方法:招募具有至少三个离散AK的个体。使用非相干光源,将每个病变随机分配给25、50或75 mW / cm2的局部5-氨基乙酰丙酸(5-ALA)PDT。主要终点是照明过程中的疼痛,使用视觉模拟量表(VAS)进行评估。次要终点是临床结果和不良事件。结果:该研究招募了五十名成年人,他们患有150个AKs病变。 25和50 mW / cm2组之间的平均VAS评分没有显着差异(P = 0.714)。但是,与前者相比,在75 mW / cm2的组中,平均VAS显着更高(P = 0.000)。关于随访第一年的临床结果和不良事件,三组之间未观察到差异。 25 mW / cm2和50 mW / cm2之间的比较(P = 0.749),以及前者和75 mW / cm2之间的比较,没有显示出完全响应速率对注量的依赖性(分别为P = 0.749和P = 1.000) )。结论:根据我们的观察,局部5-ALA PDT治疗AKs的患者有效通量率为25至50 mW / cm2。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号